Thema
Letter
COVID-19
513
Spike Glycoprotein, Coronavirus
389
Comment
291
SARS-CoV-2
291
spike protein, SARS-CoV-2
291
Coronavirus
261
Research Support, Non-U.S. Gov't
256
coronavirus
244
Antibodies, Viral
179
COVID-19 Vaccines
100
Antibodies, Neutralizing
97
Angiotensin-Converting Enzyme 2
92
EC 3.4.17.23
92
viruses
84
severe acute respiratory syndrome coronavirus 2
76
coronavirus disease
66
zoonoses
64
ACE2 protein, human
61
respiratory infections
58
Case Reports
57
Research Support, N.I.H., Extramural
49
Coronavirus disease 2019
44
Pandemic
39
Antiviral Agents
38
BNT162 Vaccine
38
N38TVC63NU
38
RNA, Viral
38
Immunoglobulin G
37
EC 3.4.15.1
36
Peptidyl-Dipeptidase A
36
pandemic
32
Coronavirus Nucleocapsid Proteins
29
coronavirus disease 2019
26
2019 novel coronavirus disease
24
Phosphoproteins
24
Covid-19
23
nucleocapsid phosphoprotein, SARS-CoV-2
23
Coronavirus disease 2019 (COVID-19)
22
Pandemics
22
virus classification
22
Coronavirus Infections
20
SARS
20
Viral Vaccines
20
Antibodies, Monoclonal
18
Severe acute respiratory syndrome coronavirus 2
18
Viral Envelope Proteins
18
China
17
Review
17
epidemiology
17
mehr ...